Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling

Magnetic Resonance Imaging

Volumn 29, Issue 7, 2011, Pages 993-1001

  Huang, Jiayi ^a   Wang, Ay Ming ^a   Shetty, Anil ^a   Maitz, Ann H ^a   Yan, Di ^a   Doyle, Danielle ^b   Richey, Kenneth ^a   Park, Sean ^a   Pieper, Daniel R ^a   Chen, Peter Y ^a   Grills, Inga Siiner ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastasis; Magnetic resonance spectroscopy; Perfusion magnetic resonance imaging; Radiation injury; Radiation necrosis; Radiosurgery; Volume modeling

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ARTICLE; BRAIN BLOOD VOLUME; BRAIN LEVEL; BRAIN METASTASIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVERALL SURVIVAL; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SKULL IRRADIATION; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERFUSION; RADIATION INJURIES; RADIOSURGERY; ROC CURVE;

EID: 80051693917     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.04.004     Document Type: Article

References (24)

1. Soussain C., Ricard D., Fike J.R., Mazeron J.J., Psimaras D., Delattre J.Y. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374(9701):1639-1651.
2. Lawrence Y.R., Li X.A., el Naqa I., Hahn C.A., Marks L.B., Merchant T.E., et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010, 76(3 Suppl):S20-S27.
3. Blonigen B.J., Steinmetz R.D., Levin L., Lamba M.A., Warnick R.E., Breneman J.C. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010, 77(4):996-1001.
4. Flickinger J.C., Kondziolka D., Lunsford L.D., Kassam A., Phuong L.K., Liscak R., et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Int J Radiat Oncol Biol Phys 2000, 46(5):1143-1148.
5. Schlemmer H.P., Bachert P., Herfarth K.K., Zuna I., Debus J., van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 2001, 22(7):1316-1324.
6. Sugahara T., Korogi Y., Tomiguchi S., Shigematsu Y., Ikushima I., Kira T., et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000, 21(5):901-909.
7. Weybright P., Sundgren P.C., Maly P., Hassan D.G., Nan B., Rohrer S., et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005, 185(6):1471-1476.
8. Sundgren P.C. MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 2009, 30(8):1469-1476.
9. Constantinidis I. MRS methodology. Adv Neurol 2000, 83:235-246.
10. Gillies R.J., Morse D.L. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 2005, 7:287-326.
11. Nighoghossian N., Berthezene Y., Meyer R., Cinotti L., Adeleine P., Philippon B., et al. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging. J Neurol Sci 1997, 149(2):171-176.
12. Speck O., Chang L., DeSilva N.M., Ernst T. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging 2000, 12(3):381-387.
13. Vonken E.P., van Osch M.J., Bakker C.J., Viergever M.A. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000, 43(6):820-827.
14. Rydberg J.N., Hammond C.A., Grimm R.C., Erickson B.J., Jack C.R., Huston J., et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 1994, 193(1):173-180.
15. White S.J., Hajnal J.V., Young I.R., Bydder G.M. Use of fluid-attenuated inversion-recovery pulse sequences for imaging the spinal cord. Magn Reson Med 1992, 28(1):153-162.
16. Smith E.A., Carlos R.C., Junck L.R., Tsien C.I., Elias A., Sundgren P.C. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. AJR Am J Roentgenol 2009, 192(2):W45-W52.
17. Zeng Q.S., Li C.F., Zhang K., Liu H., Kang X.S., Zhen J.H. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007, 84(1):63-69.
18. Barajas R.F., Chang J.S., Sneed P.K., Segal M.R., McDermott M.W., Cha S. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009, 30(2):367-372.
19. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280(17):1485-1489.
20. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143(1):29-36.
21. Rutkowski T., Tarnawski R., Sokol M., Maciejewski B. 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 2003, 56(5):1381-1389.
22. Devos A., Lukas L., Suykens J.A., Vanhamme L., Tate A.R., Howe F.A., et al. Classification of brain tumours using short echo time 1H MR spectra. J Magn Reson 2004, 170(1):164-175.
23. Rock J.P., Hearshen D., Scarpace L., Croteau D., Gutierrez J., Fisher J.L., et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002, 51(4):912-919. [discussion 919-920].
24. Mayer R., Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008, 70(5):1350-1360.